(Alliance News) - Shares in Catenae Innovation PLC rose over 30% on Monday morning following the announcement of a new partnership with medical sample technology specialist ProMake Ltd.
Shares were trading 31% higher at 1.38 pence each in London.
Under the new partnership, Catenae will be the exclusive provider of data management services for ProMake to fulfil its position on the Public Health England National Microbiology Framework.
The National Microbiology Framework supports the newly formed UK Health Security Agency and the UK government's effort to provide a range of medical testing and diagnostic services for members of the public.
The Newcastle-based digital media and technology company's role within the contract will be to capture patient and test data, control access to the data and provide reporting services for individuals and organisations.
Catenae Chief Executive Guy Meyer commented: "We are delighted to announce this collaboration agreement with ProMake to support its work within the Public Health England National Microbiology Framework.
"Our data management services can be successfully applied to a number of sectors and industries, with Covid-19 testing and related services a continued area of work for Catenae."
Catenae would not provide any guidance as to the timing or value of the partnership.
ProMake specialises in technology that uses nano-materials within an injection moulded tube, which a patient blows into in order to provide medical samples. The test can then be used to diagnose different diseases using a less invasive method and at a potentially lower cost to conventional methods.
By Will Paige; willpaige@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
